+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Orthostatic Hypotension Drugs Market by Product (Droxidopa, Fludrocortisone, Indomethacin), Diagnostics Test type (Blood Tests, ECG, Echocardiogram), End-Use - Forecast 2024-2030- Product Image
Global Orthostatic Hypotension Drugs Market by Product (Droxidopa, Fludrocortisone, Indomethacin), Diagnostics Test type (Blood Tests, ECG, Echocardiogram), End-Use - Forecast 2024-2030- Product Image
Sale

Global Orthostatic Hypotension Drugs Market by Product (Droxidopa, Fludrocortisone, Indomethacin), Diagnostics Test type (Blood Tests, ECG, Echocardiogram), End-Use - Forecast 2024-2030

  • PDF Icon

    Report

  • 198 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4968623
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Orthostatic Hypotension Drugs Market size was estimated at USD 879.78 million in 2023, USD 953.89 million in 2024, and is expected to grow at a CAGR of 8.51% to reach USD 1,559.07 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Orthostatic Hypotension Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Orthostatic Hypotension Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Orthostatic Hypotension Drugs Market, highlighting leading vendors and their innovative profiles. These include Amgen Inc., Apotex Inc., Boehringer Ingelheim GmbH, Eli Lilly and Company, F. Hoffmann-La Roche AG, H. Lundbeck A/S, Koninklijke Philips N.V., Lupin Limited, Merck KGaA, Mylan N.V., Novartis AG, PerkinElmer Inc., Pfizer Inc., Sun Pharmaceutical Industries, Inc., and Takeda Pharmaceutical Company Limited.

Market Segmentation & Coverage

This research report categorizes the Orthostatic Hypotension Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Droxidopa
    • Fludrocortisone
    • Indomethacin
    • Midodrine Hydrochloride
    • NSAIDs
    • Pyridostigmine
  • Diagnostics Test type
    • Blood Tests
    • ECG
    • Echocardiogram
    • Stress Test
  • End-Use
    • Ambulatory Surgical Centers
    • Clinics
    • Diagnostic Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Orthostatic Hypotension Drugs Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Orthostatic Hypotension Drugs Market?
  3. What are the technology trends and regulatory frameworks in the Orthostatic Hypotension Drugs Market?
  4. What is the market share of the leading vendors in the Orthostatic Hypotension Drugs Market?
  5. Which modes and strategic moves are suitable for entering the Orthostatic Hypotension Drugs Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Orthostatic Hypotension Drugs Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growth in the prevalence of chronic diseases associated with high risk of orthostatic hypotension
5.1.1.2. High pharmaceutical expenditure and increased awareness of orthostatic hypotension
5.1.1.3. Presence of several major players and improvement in healthcare facilities
5.1.2. Restraints
5.1.2.1. Hypotensive medications frequently overlap with other risk factors increasing further complications
5.1.3. Opportunities
5.1.3.1. Integration of advanced technologies in healthcare
5.1.3.2. Large investments and collaborations for development of new drugs
5.1.4. Challenges
5.1.4.1. Difficult to improve the symptoms of orthostatic hypotension without inducing some degree of supine hypertension
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Orthostatic Hypotension Drugs Market, by Product
6.1. Introduction
6.2. Droxidopa
6.3. Fludrocortisone
6.4. Indomethacin
6.5. Midodrine Hydrochloride
6.6. NSAIDs
6.7. Pyridostigmine
7. Orthostatic Hypotension Drugs Market, by Diagnostics Test type
7.1. Introduction
7.2. Blood Tests
7.3. ECG
7.4. Echocardiogram
7.5. Stress Test
8. Orthostatic Hypotension Drugs Market, by End-Use
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Clinics
8.4. Diagnostic Centers
8.5. Hospitals
9. Americas Orthostatic Hypotension Drugs Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Orthostatic Hypotension Drugs Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Orthostatic Hypotension Drugs Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Amgen Inc.
13.1.2. Apotex Inc.
13.1.3. Boehringer Ingelheim GmbH
13.1.4. Eli Lilly and Company
13.1.5. F. Hoffmann-La Roche AG
13.1.6. H. Lundbeck A/S
13.1.7. Koninklijke Philips N.V.
13.1.8. Lupin Limited
13.1.9. Merck KGaA
13.1.10. Mylan N.V.
13.1.11. Novartis AG
13.1.12. PerkinElmer Inc.
13.1.13. Pfizer Inc.
13.1.14. Sun Pharmaceutical Industries, Inc.
13.1.15. Takeda Pharmaceutical Company Limited
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. ORTHOSTATIC HYPOTENSION DRUGS MARKET RESEARCH PROCESS
FIGURE 2. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ORTHOSTATIC HYPOTENSION DRUGS MARKET DYNAMICS
FIGURE 7. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2023 VS 2030 (%)
FIGURE 10. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 12. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ORTHOSTATIC HYPOTENSION DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. ORTHOSTATIC HYPOTENSION DRUGS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. ORTHOSTATIC HYPOTENSION DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DROXIDOPA, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY FLUDROCORTISONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY INDOMETHACIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY MIDODRINE HYDROCHLORIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY NSAIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PYRIDOSTIGMINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 13. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY ECG, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY ECHOCARDIOGRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY STRESS TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 18. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 32. CANADA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. CANADA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 34. CANADA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 35. MEXICO ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. MEXICO ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 37. MEXICO ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 48. AUSTRALIA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 49. CHINA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. CHINA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 51. CHINA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 52. INDIA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. INDIA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 54. INDIA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. INDONESIA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 57. INDONESIA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 58. JAPAN ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. JAPAN ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 60. JAPAN ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. MALAYSIA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 63. MALAYSIA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. PHILIPPINES ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 66. PHILIPPINES ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. SINGAPORE ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 69. SINGAPORE ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. SOUTH KOREA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 72. SOUTH KOREA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. TAIWAN ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 75. TAIWAN ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 76. THAILAND ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. THAILAND ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 78. THAILAND ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. VIETNAM ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 81. VIETNAM ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 86. DENMARK ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. DENMARK ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 88. DENMARK ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 89. EGYPT ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. EGYPT ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 91. EGYPT ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 92. FINLAND ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. FINLAND ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 94. FINLAND ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 95. FRANCE ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. FRANCE ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 97. FRANCE ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 98. GERMANY ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. GERMANY ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 100. GERMANY ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. ISRAEL ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 103. ISRAEL ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 104. ITALY ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. ITALY ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 106. ITALY ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. NETHERLANDS ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 109. NETHERLANDS ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 112. NIGERIA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 113. NORWAY ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. NORWAY ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 115. NORWAY ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 116. POLAND ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. POLAND ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 118. POLAND ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 119. QATAR ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. QATAR ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 121. QATAR ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 127. SAUDI ARABIA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 130. SOUTH AFRICA ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 131. SPAIN ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. SPAIN ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 133. SPAIN ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 136. SWEDEN ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 139. SWITZERLAND ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 140. TURKEY ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. TURKEY ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 142. TURKEY ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY DIAGNOSTICS TEST TYPE, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM ORTHOSTATIC HYPOTENSION DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 149. ORTHOSTATIC HYPOTENSION DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 150. ORTHOSTATIC HYPOTENSION DRUGS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 151. ORTHOSTATIC HYPOTENSION DRUGS MARKET LICENSE & PRICING

Companies Mentioned

  • Amgen Inc.
  • Apotex Inc.
  • Boehringer Ingelheim GmbH
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • H. Lundbeck A/S
  • Koninklijke Philips N.V.
  • Lupin Limited
  • Merck KGaA
  • Mylan N.V.
  • Novartis AG
  • PerkinElmer Inc.
  • Pfizer Inc.
  • Sun Pharmaceutical Industries, Inc.
  • Takeda Pharmaceutical Company Limited

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages198
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 953.89 Million
Forecasted Market Value ( USD ) by 2030 $ 1559.07 Million
Compound Annual Growth Rate8.5%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Orthostatic Hypotension Drugs Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F - Product Image

Orthostatic Hypotension Drugs Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

  • Report
  • 190 Pages
  • Global
From
Orthostatic Hypotension Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Orthostatic Hypotension Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 85 Pages
  • Global
From
Droxidopa (CAS 23651-95-8) Global Market Research Report 2024 - Product Image

Droxidopa (CAS 23651-95-8) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Practical Cardiovascular Medicine. Edition No. 2 - Product Image

Practical Cardiovascular Medicine. Edition No. 2

  • Book
  • 992 Pages
Adrenergic uptake inhibitors - Pipeline Insight, 2024 - Product Image

Adrenergic uptake inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • 60 Pages
  • Global
From

About the Hypotension Drug Market

The Hypotension Drug market is a subset of the Cardiovascular Drugs market, which includes drugs used to treat conditions related to the heart and circulatory system. Hypotension Drugs are used to treat low blood pressure, a condition in which the force of the blood against the artery walls is too low. These drugs work by increasing the amount of blood pumped by the heart, increasing the diameter of the blood vessels, and reducing the amount of fluid in the body. Commonly prescribed Hypotension Drugs include diuretics, ACE inhibitors, calcium channel blockers, and alpha-blockers. Some of the major companies in the Hypotension Drug market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.